Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. - Wikidata - wikimedia - TriplyDB

Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge.

Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge.

http://www.wikidata.org/entity/Q43849061

about

Melatonin for women in pregnancy for neuroprotection of the fetus Melatonin for women in pregnancy for neuroprotection of the fetus Neurotransmitter receptors in the life and death of oligodendrocytes Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases What are the Best Animal Models for Testing Early Intervention in Cerebral Palsy?Protective role of melatonin in neonatal diseases Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat Pathophysiology of glia in perinatal white matter injury.Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats.Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?Synergistic neuroprotective therapies with hypothermia.HIP/PAP prevents excitotoxic neuronal death and promotes plasticity.The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion.Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury.Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage Regiospecific synthesis of neuroprotective 1,4-benzoxazine derivatives through a tandem oxidation-Diels-Alder reaction.Protective effects of intermittent hypoxia on brain and memory in a mouse model of apnea of prematurity.The role of inflammation in perinatal brain injury.New horizons for newborn brain protection: enhancing endogenous neuroprotection Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits.Perinatal brain damage: The term infant.Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?Pharmacokinetics of melatonin in preterm infants.Partial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep.Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?Hepatoprotective actions of melatonin: possible mediation by melatonin receptors A new neurological focus in neonatal intensive care.Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury.Bench to cribside: the path for developing a neuroprotectant.Melatonin in animal models.Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor.Brain-derived neurotrophic factor-mediated effects on mitochondrial respiratory coupling and neuroprotection share the same molecular signalling pathways.Early metabolite changes after melatonin treatment in neonatal rats with hypoxic-ischemic brain injury studied by in-vivo1H MR spectroscopy Oxidative stress and endoplasmic reticulum (ER) stress in the development of neonatal hypoxic-ischaemic brain injury.Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model.Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation.Potent mammalian cerebroprotection and neuronal cell death inhibition are afforded by a synthetic antioxidant analogue of marine invertebrate cell protectant ovothiols.Role of tissue-derived plasminogen activator (t-PA) in an excitotoxic mouse model of neonatal white matter lesions.

P2860

Q24186003-9D5637C4-DAE0-4A9A-8AFD-E4E4999188D9 Q24202969-C78E3DD6-BF2F-47C9-86FF-8203A6DFEEA9 Q24671657-3CDA2A2E-C012-4951-9E83-81347EA183C6 Q26772733-5EC1674B-FFD3-4E80-B21B-DAAF13E8D268 Q26829589-8B92D980-619B-45E9-A3BF-E68703FEE6F9 Q26861881-B1D530F4-6FFD-4890-92AB-0ABFB48B8B37 Q27000069-01B0D5C9-5D78-4840-A59B-BFA42D423923 Q28751833-B17C403F-9BBA-4C5E-B1FC-5BDC86D3BC1F Q30790294-A415D0F9-3EEF-4D69-A5FA-2FE26A18CEA9 Q33505669-E4D3209F-1E8A-4BAA-9429-7CED41392619 Q33723452-84413A9B-FD23-44F7-8880-1975BF0476D2 Q33943360-67CDCB45-2DAA-44ED-943D-F0545307913E Q34562834-55B3820A-E91D-4C81-B846-ADE9C6377F2E Q35076749-11329409-1876-4245-8412-F518694C421C Q35118398-6CA3EB90-0003-4538-B247-DD6D1F7955B5 Q35123174-337C83FB-1102-485A-8DA5-4AA0C77656A6 Q35546025-578BA30F-70A5-4052-9561-4B0857934456 Q35562211-9833B65C-D70D-48E5-80A8-869D9E7D9595 Q36245553-3D6BDB7A-AE10-4596-B541-25FA6B2969C2 Q36331560-054B40C0-90E7-4A56-A15B-6C5E7301A749 Q36374839-4B6F808A-5849-4AB3-8532-16BF9B946954 Q36954980-A55FDB06-19CE-4D5F-9771-5E66277032DE Q37025326-DCEABCEA-7889-4C81-9C8E-3478396C4767 Q37302940-87D26EC4-BB9B-4F3B-875A-648CB831E147 Q37369312-07DA6EF5-0A38-4FC7-BDD7-CCE65129D916 Q37459886-53401292-F246-4D1C-8726-4A714AB21C8B Q37686303-7DD98017-9D73-4322-88E3-FA3F5E070A24 Q37823548-CF75BA8F-AEEA-4B0C-9F86-39CA5EBB09A9 Q37909914-FDBA7B63-BF15-4A8F-ACB2-88BFBEB76DAC Q37976090-2769B7BD-B18A-44D1-92F3-1A292E566A44 Q38169987-EFAE9342-5DFE-4E02-951A-6CC057EA57AB Q38580390-8CAA7F7C-215D-498F-9F64-D42577F6011D Q38630639-53C5491E-7959-4522-BE97-FDAB30DC2AD1 Q39404472-3D6CF2B1-EAAF-49E3-BB45-66DF910B3328 Q42362136-897B0C4B-AE29-4ECC-A52A-D9212DDD10C0 Q42650888-19B5DCC4-2081-48F5-9F7A-7A247B061EBF Q44099805-B04363D0-9C0A-4A51-A984-1A05A274D43B Q44340071-AA96811E-6FBB-4F61-84E5-9675D505A674 Q44574088-4B78AD84-370F-4E0E-91C3-A19AD1CEB338 Q44745874-B32EF7FC-853B-4229-B234-52C0A3C073D9

P2860

Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge.

http://www.wikidata.org/entity/Q43849061

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@en

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@nl

type

label

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@en

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@nl

prefLabel

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@en

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@nl

P1433

Q43849061-4D9F67A7-9DB7-4E74-A331-81543068B8AC

P1476

Q43849061-4494B8BD-92DE-4196-B24F-9F7C06591B94

P2093

Q43849061-30642241-A9F2-4EE4-8632-EA372AF52E32

Q43849061-4965142F-7632-4C20-BF40-F64DEDE6D3A9

Q43849061-AB24B5B3-F983-47CF-BDB3-90395864CBA6

Q43849061-B974562F-87A3-4219-A61D-FA83BCC23D7D

P2860

Q43849061-194727F5-D6DC-4528-AAAD-BF44D15E9945

Q43849061-2D9E6D00-2852-4AE3-BC77-A0067F99FED5

Q43849061-303C2DA9-F40C-4831-A919-9CB10E52420D

Q43849061-31F3F5AD-18F9-4BFB-AE82-4E2DEAF4BA63

Q43849061-5668A536-FDB8-4F25-B23F-B51ADCCEE465

Q43849061-60EC9F1F-3C7A-4797-BFA6-15D3FF58B48F

Q43849061-65BC22A6-701F-48A6-82B5-34EC7648AA55

Q43849061-66D4323D-591E-44CB-AA16-570063F4C1BB

Q43849061-68E0771D-9273-4985-8183-F8388880C3E4

Q43849061-7D1E789E-E7EF-44EA-A603-DC37EB700B3F

P304

Q43849061-798429F6-061D-41E9-9D58-D38FF9A0F968

P31

Q43849061-7146AF74-319F-425F-AAE9-E6F6180BF65C

P356

Q43849061-6D2FE811-CABD-4A5D-8CFB-5E7A468F94FB

P433

Q43849061-1CB9D94D-3043-4359-8C72-FC2A0DA3EDAF

P478

Q43849061-DCD784A2-EE22-446C-B0A1-6FA2744FFE0C

P50

Q43849061-DCEA2882-4FD6-49BF-B321-AB9D199EA92A

Q43849061-FCDA2EE6-815C-43D6-B0EE-0B15923E3A53

P577

Q43849061-4354420B-4432-4027-9ACE-260BCD0C1549

P5875

Q43849061-4D1BC12A-5C98-4C79-8B97-9C5397F012AF

P698

Q43849061-F660D49E-A2AA-44B1-BC9C-9B8972336C9F

P356

P1433

Annals of Neurology

P1476

Melatoninergic neuroprotection ...... eonatal excitotoxic challenge.

@en

P2093

Bettina Mesplès

http://www.w3.org/2001/XMLSchema#string

Isabelle Husson

http://www.w3.org/2001/XMLSchema#string

Joseph Vamecq

http://www.w3.org/2001/XMLSchema#string

Pierre Bac

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis.

Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia.

Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance.

Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain

Melatonin: a clinical perspective.

Cell protective role of melatonin in the brain.

Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.

Melatonin effects on behavior: possible mediation by the central GABAergic system.

P304

82-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.10072

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Evrard

Pierre Gressens

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11575280

http://www.w3.org/2001/XMLSchema#string

P698

11782987

http://www.w3.org/2001/XMLSchema#string